Back to Search
Start Over
CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value
- Source :
- Advances in Laboratory Medicine, Vol 1, Iss 4, Pp 160-5 (2020)
- Publication Year :
- 2020
- Publisher :
- De Gruyter, 2020.
-
Abstract
- Chosen cutoff for cytokeratin 19 fragment antigen (CYFRA 21-1) as a tumor biomarker considerably influences its diagnostic and prognostic usefulness. The aim of the present study is to determine an optimal cutoff value for diagnostic validity of CYFRA 21-1 by Lumipulse ® technology in patients with suspected cancer and also to determine if CYFRA 21-1 levels provide prognostic value.
Details
- Language :
- English, Spanish; Castilian
- ISSN :
- 2628491X and 20200005
- Volume :
- 1
- Issue :
- 4
- Database :
- Directory of Open Access Journals
- Journal :
- Advances in Laboratory Medicine
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.982c08d81cda467fa39bf2018dbdc8d1
- Document Type :
- article
- Full Text :
- https://doi.org/10.1515/almed-2020-0005